Clinical Trial Update: Axelopran in Advanced Cancers [Phase 2]

View source ↗

Summary

Axelopran is being studied in a Phase 2 trial across several advanced cancers, but the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Lung Cancer
• Pancreatic Cancer
• Prostate Cancer

Drugs mentioned

• Axelopran

Snippet

Sponsor: HealthPartners Institute | Conditions: Breast Cancer, Lung Cancer | Phase 2 | Status: NOT_YET_RECRUITING